chlordiazepoxide 5mg capsules
sigma pharmaceuticals plc - chlordiazepoxide hydrochloride - oral capsule - 5mg
chlordiazepoxide 5mg capsules
waymade healthcare plc - chlordiazepoxide hydrochloride - oral capsule - 5mg
cevaxel-rtu 50 mg/ml inj. susp. i.m./s.c. vial
ceva santé animale sa-nv - ceftiofur hydrochloride - eq. ceftiofur 50 mg/ml - suspension for injection - 50 mg/ml - ceftiofur hydrochloride - ceftiofur - cattle; pig
levaxa 500 mg/100 ml solution for iv infusion
amb hk enterprise inc.; distributor: amb hk enterprise inc. - levofloxacin - solution for iv infusion - 500 mg/100 ml
levoxel 5mg/ml (750mg/150ml) solution for iv infusion
international apex pharmaceuticals, inc.; distributor: international apex pharmaceuticals, inc. - levofloxacin (as hemihydrate) - solution for iv infusion - 5mg/ml (750mg/150ml)
cevaxel 50 mg/ml inj. sol. (pwdr. + solv.) i.m. vial
ceva santé animale sa-nv - ceftiofur sodium - eq. ceftiofur 50 mg/ml - powder and solvent for solution for injection - 50 mg/ml - ceftiofur sodium - ceftiofur - cattle; pig
cevaxel rtu suspension for injection
ceva santé animale, france - ceftiofur hydrochloride - suspension for injection - 50 mg/ml
cevaxel rtu solution for injection
ceva santÉ animale 10 avenue de la ballastière, 33500 libourne. - ceftiofur (as hydrochloride) - solution for injection - ceftiofur (as hydrochloride) .. 50mg/ml - third-generation cephalosporins
clevecord (hpc- hematopoietic progenitor cell, cord blood injection, suspension
cleveland cord blood center - human cord blood hematopoietic progenitor cell (unii: xu53vk93mc) (human cord blood hematopoietic progenitor cell - unii:xu53vk93mc) - human cord blood hematopoietic progenitor cell 500000000 in 25 ml - clevecord, hpc (hematopoietic progenitor cell), cord blood, is an allogeneic cord blood hematopoietic progenitor cell therapy indicated for use in unrelated donor hematopoietic progenitor stem cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. the risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on characteristics of the graft, and on other available treatments or types of hematopoietic progenitor cells. none. risk summary there are no data with clevecord use in pregnant women to inform a product-associated risk. animal reproduction studies have not been conducted with clevecord. in the u.s. general population, the estimated background risk of major birth defects and misca
spray once aerosol fly and insect spray
cleveland chemical co pty ltd - bioresmethrin | tetramethrin - household insecticide - commercial/industrial premises | pest c. institutional, business premises | premises - ant | beetle | cockroach | flea | fly | mosquito | moth | sand fly (biting midge) | silverfish | spider | adult | adult mosquitoes | argentine ant | ctenocephalides spp. | ground fleas | large cockroach | pharaoh ant | small cockroach